Australia's most trusted
source of pharma news
Monday, 30 June 2025
Posted 25 June 2025 Ath
A raft of companies have been busy lining up new uses for their drugs that could hit the Australian market early 2026 – with the possible expansion of one drug feeding analysts’ predictions that the drug class could be the first to reach US$100 billion in sales.
In the three months to May, the TGA accepted 14 Type C applications, also known as new indication applications.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.